Exact Mass: 483.33484100000004

Exact Mass Matches: 483.33484100000004

Found 119 metabolites which its exact mass value is equals to given mass value 483.33484100000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Taurolithocholate

2-[(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid

C26H45NO5S (483.301828)


Lithocholyltaurine is a bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. Lithocholic acid, a hydrophobic secondary bile acid, is well known to cause intrahepatic cholestasis. There have been extensive studies on the mechanisms of lithocholate-induced cholestasis in animals. Lithocholate diminishes both the bile acid-dependent and independent bile flow. In humans, elevated levels of lithocholic acid are found in patients with chronic cholestatic liver disease. Lithocholyltaurine impairs both the bile canalicular contractions and the canalicular bile secretion, possibly by acting directly on the canalicular membranes in lithocholyltaurine-induced cholestasis. Lithocholyltaurine induce acute cholestasis-associated with retrieval of the bile salt export pump. The bile salt export pump (BSEP) of hepatocyte secretes conjugated bile salts across the canalicular membrane in an ATP-dependent manner. Hepatic retention of bile acids may lead to liver injury by hepatocyte apoptosis and eventually deterioration of cholestatic liver diseases. One mechanism of induced apoptosis by lithocholyltaurine is the induction of transcriptional activity of AP-1 (activation protein-1). (PMID: 16981261, 15763547, 16332456, 18164257) [HMDB] Lithocholyltaurine is a bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. Lithocholic acid, a hydrophobic secondary bile acid, is well known to cause intrahepatic cholestasis. There have been extensive studies on the mechanisms of lithocholate-induced cholestasis in animals. Lithocholate diminishes both the bile acid-dependent and independent bile flow. In humans, elevated levels of lithocholic acid are found in patients with chronic cholestatic liver disease. Lithocholyltaurine impairs both the bile canalicular contractions and the canalicular bile secretion, possibly by acting directly on the canalicular membranes in lithocholyltaurine-induced cholestasis. Lithocholyltaurine induce acute cholestasis-associated with retrieval of the bile salt export pump. The bile salt export pump (BSEP) of hepatocyte secretes conjugated bile salts across the canalicular membrane in an ATP-dependent manner. Hepatic retention of bile acids may lead to liver injury by hepatocyte apoptosis and eventually deterioration of cholestatic liver diseases. One mechanism of induced apoptosis by lithocholyltaurine is the induction of transcriptional activity of AP-1 (activation protein-1). (PMID: 16981261, 15763547, 16332456, 18164257). D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents CONFIDENCE standard compound; INTERNAL_ID 61

   
   
   

Hydroxybuprenorphine

Hydroxybuprenorphine

C29H41NO5 (483.29845760000006)


Hydroxybuprenorphine is a metabolite of Buprenorphine. Buprenorphine is a semi-synthetic opioid that is used to treat opioid addiction in higher dosages (>2 mg), to control moderate acute pain in non-opioid-tolerant individuals in lower dosages (~200 µg), and to control moderate chronic pain in dosages ranging from 20–70 µg/hour. It is available in a variety of formulations: Subutex, Suboxone (buprenorphine HCl and naloxone HCl; typically used for opioid addiction), Temgesic (sublingual tablets for moderate to severe pain), Buprenex (solutions for injection often used for acute pain in primary-care settings), Norspan and Butrans (transdermal preparations used for chronic pain). (Wikipedia)

   
   
   

1beta-hydroxy-tirucalla-3,23-dione-7,24-diene-1(2->3)abeo-1-carboxamide|aphanamgrandin F

1beta-hydroxy-tirucalla-3,23-dione-7,24-diene-1(2->3)abeo-1-carboxamide|aphanamgrandin F

C30H45NO4 (483.33484100000004)


   
   

Taurolithocholic acid

Taurolithocholic acid

C26H45NO5S (483.30182800000006)


D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents The bile acid taurine conjugate of lithocholic acid. KEIO_ID T072

   

MLS001304001-01! Cholylglycine

MLS001304001-01! Cholylglycine

C26H45NO7 (483.319586)


   

Tauro 3a-OH-5b-cholanic acid

Tauro 3a-OH-5b-cholanic acid

C26H45NO5S (483.30182800000006)


BA-134-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-134-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-134-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-134-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

2-((4R)-4-((5S,9S,10S,12R,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

"2-((4R)-4-((5S,9S,10S,12R,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid"

C26H45NO5S (483.30182800000006)


   

2-((4R)-4-((3R,5R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

"2-((4R)-4-((3R,5R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid"

C26H45NO5S (483.30182800000006)


   

2-((4R)-4-((5S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

"2-((4R)-4-((5S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid"

C26H45NO5S (483.30182800000006)


   

Lithocholyltaurine

Lithocholyltaurine

C26H45NO5S (483.30182800000006)


D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents

   

Ile Pro Arg Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Ile Pro Val Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C22H41N7O5 (483.31690160000005)


   

Ile Arg Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Ile Arg Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Ile Val Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C22H41N7O5 (483.31690160000005)


   

Ile Val Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Leu Pro Arg Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Leu Pro Val Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C22H41N7O5 (483.31690160000005)


   

Leu Arg Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Leu Arg Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Leu Val Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C22H41N7O5 (483.31690160000005)


   

Leu Val Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Pro Ile Arg Val

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Ile Val Arg

(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]pentanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Leu Arg Val

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Leu Val Arg

(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]pentanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Arg Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Arg Leu Val

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Arg Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Arg Val Leu

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Val Ile Arg

(2S)-5-carbamimidamido-2-[(2S,3S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]pentanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Val Leu Arg

(2S)-5-carbamimidamido-2-[(2S)-4-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]pentanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Val Arg Ile

(2S,3S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]-3-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Pro Val Arg Leu

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]-4-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Arg Ile Pro Val

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Arg Ile Val Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Arg Leu Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Arg Leu Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Arg Pro Ile Val

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Arg Pro Leu Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-methylbutanoic acid

C22H41N7O5 (483.31690160000005)


   

Arg Pro Val Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Arg Pro Val Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-4-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Arg Val Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Arg Val Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Arg Val Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Arg Val Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Val Ile Pro Arg

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C22H41N7O5 (483.31690160000005)


   

Val Ile Arg Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Val Leu Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C22H41N7O5 (483.31690160000005)


   

Val Leu Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Val Pro Ile Arg

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C22H41N7O5 (483.31690160000005)


   

Val Pro Leu Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C22H41N7O5 (483.31690160000005)


   

Val Pro Arg Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Val Pro Arg Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Val Arg Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Val Arg Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C22H41N7O5 (483.31690160000005)


   

Val Arg Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

Val Arg Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C22H41N7O5 (483.31690160000005)


   

PS(O-16:0/0:0)

1-hexadecyl-glycero-3-phosphoserine

C22H46NO8P (483.2960886)


   

LPS O-16:0

1-hexadecyl-glycero-3-phosphoserine

C22H46NO8P (483.2960886)


   

2-(Hydroxyimino)-3-oxo-olean-12-en-28-oic acid

2-(Hydroxyimino)-3-oxo-olean-12-en-28-oic acid

C30H45NO4 (483.33484100000004)


   

boc-d-dab(aloc)-oh dcha

boc-d-dab(aloc)-oh dcha

C25H45N3O6 (483.330819)


   

bis(2-hydroxyethyl)methyl(octadecyl)ammonium methyl sulphate

bis(2-hydroxyethyl)methyl(octadecyl)ammonium methyl sulphate

C24H53NO6S (483.35933980000004)


   

Glycocholic acid (hydrate)

2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid;hydrate

C26H45NO7 (483.319586)


   

Boc-Dab(Alloc)-OH·DCHA

Boc-Dab(Alloc)-OH·DCHA

C25H45N3O6 (483.330819)


   

Otilonium

Otilonium

C29H43N2O4+ (483.3222658)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D005765 - Gastrointestinal Agents

   
   
   

(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C28H38FN3O3 (483.289705)


   

(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C28H38FN3O3 (483.289705)


   

2-((4R)-4-((5S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

2-((4R)-4-((5S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO5S (483.30182800000006)


   
   

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

C31H49NO3 (483.3712244000001)


   

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

C31H49NO3 (483.3712244000001)


   

(4Z,7Z,10Z,13Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]hexadeca-4,7,10,13-tetraenamide

C31H49NO3 (483.3712244000001)


   

2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydecane-1-sulfonic acid

2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydecane-1-sulfonic acid

C26H45NO5S (483.30182800000006)


   

(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid

(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid

C26H45NO5S (483.30182800000006)


   

2-[4-[(3R,5R,8R,9S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

2-[4-[(3R,5R,8R,9S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C26H45NO5S (483.30182800000006)


   

2-[[(4R)-4-[(5S,8R,9S,10S,12R,13R,14S,17R)-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid

2-[[(4R)-4-[(5S,8R,9S,10S,12R,13R,14S,17R)-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid

C26H45NO5S (483.30182800000006)


   
   

Oxolucidine B

Oxolucidine B

C30H49N3O2 (483.3824574)


An organonitrogen heterocyclic compound that is lucidine B in which the hydrogen at the 4a position of the dodecahydrobenzo[5,6]cyclohepta[1,2-b]pyridinyl moiety is substituted by a hydroxy group.

   

hainanate A

hainanate A

C30H43O5 (483.3110328)


A steroid acid anion that is the conjugate base of hainanic acid A resulting from the deprotonation of the carboxy group; major species at pH 7.3.

   

1-hexadecyl-glycero-3-phosphoserine

1-hexadecyl-glycero-3-phosphoserine

C22H46NO8P (483.2960886)


   
   
   
   
   
   
   
   

(2r,4as,6as,6br,8ar,10z,12ar,12br,14br)-10-(methoxyimino)-2,4a,6a,6b,9,9,12a-heptamethyl-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-2-carboxylic acid

(2r,4as,6as,6br,8ar,10z,12ar,12br,14br)-10-(methoxyimino)-2,4a,6a,6b,9,9,12a-heptamethyl-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-2-carboxylic acid

C31H49NO3 (483.3712244000001)


   

5-(6-hydroxy-3,6,7-trimethyloct-1-en-3-yl)-10-isopropyl-13-(methoxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

5-(6-hydroxy-3,6,7-trimethyloct-1-en-3-yl)-10-isopropyl-13-(methoxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C29H45N3O3 (483.34607400000004)


   

3-methyl-2-({3-methyl-2-[1-(2-methyldecanoyl)pyrrolidine-2-carbonyloxy]butanoyl}oxy)butanoic acid

3-methyl-2-({3-methyl-2-[1-(2-methyldecanoyl)pyrrolidine-2-carbonyloxy]butanoyl}oxy)butanoic acid

C26H45NO7 (483.319586)


   

9,18,20,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

9,18,20,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

C29H41NO5 (483.29845760000006)


   

methyl (2z,6s)-6-[(1s,3as,5ar,7e,9ar,9br,11as)-7-(hydroxyimino)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate

methyl (2z,6s)-6-[(1s,3as,5ar,7e,9ar,9br,11as)-7-(hydroxyimino)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate

C31H49NO3 (483.3712244000001)


   

methyl (3s,3'r,3'as,6's,6as,6bs,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-11-oxo-1,2,3,3',3'a,4,5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydrospiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-4'-carboxylate

methyl (3s,3'r,3'as,6's,6as,6bs,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-11-oxo-1,2,3,3',3'a,4,5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydrospiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-4'-carboxylate

C29H41NO5 (483.29845760000006)


   

3-[(4e,6e,8s,11z)-13-[(2s)-5-hydroxy-4-methyl-3-oxo-2h-furan-2-yl]-4,8,12-trimethyltrideca-4,6,11-trien-1-yl]-1-(3-methylbutyl)-5h-pyrrol-2-one

3-[(4e,6e,8s,11z)-13-[(2s)-5-hydroxy-4-methyl-3-oxo-2h-furan-2-yl]-4,8,12-trimethyltrideca-4,6,11-trien-1-yl]-1-(3-methylbutyl)-5h-pyrrol-2-one

C30H45NO4 (483.33484100000004)


   

3-[13-(3-hydroxy-4-methyl-5-oxo-2h-furan-2-yl)-4,8,12-trimethyltrideca-4,6,11-trien-1-yl]-1-(3-methylbutyl)-5h-pyrrol-2-one

3-[13-(3-hydroxy-4-methyl-5-oxo-2h-furan-2-yl)-4,8,12-trimethyltrideca-4,6,11-trien-1-yl]-1-(3-methylbutyl)-5h-pyrrol-2-one

C30H45NO4 (483.33484100000004)


   

(9s,10r,11r,12s,14r,15e,26s)-9,19,21,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

(9s,10r,11r,12s,14r,15e,26s)-9,19,21,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

C29H41NO5 (483.29845760000006)


   

(10s,13s)-5-[(3r)-6-hydroxy-3,6,7-trimethyloct-1-en-3-yl]-10-isopropyl-13-(methoxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

(10s,13s)-5-[(3r)-6-hydroxy-3,6,7-trimethyloct-1-en-3-yl]-10-isopropyl-13-(methoxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C29H45N3O3 (483.34607400000004)


   

(2s,4's,6r,6'r,8's,9'r)-6-{[(4ar,5r,7s,8as)-1-acetyl-7-methyl-octahydro-2h-quinolin-5-yl]methyl}-6',12'-dimethyl-12'-azaspiro[piperidine-2,2'-tricyclo[6.2.2.0⁴,⁹]dodecan]-3-one

(2s,4's,6r,6'r,8's,9'r)-6-{[(4ar,5r,7s,8as)-1-acetyl-7-methyl-octahydro-2h-quinolin-5-yl]methyl}-6',12'-dimethyl-12'-azaspiro[piperidine-2,2'-tricyclo[6.2.2.0⁴,⁹]dodecan]-3-one

C30H49N3O2 (483.3824574)


   

1-[5-({2-hydroxy-11,14-dimethyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadec-6-en-5-yl}methyl)-7-methyl-octahydro-2h-quinolin-1-yl]ethanone

1-[5-({2-hydroxy-11,14-dimethyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadec-6-en-5-yl}methyl)-7-methyl-octahydro-2h-quinolin-1-yl]ethanone

C30H49N3O2 (483.3824574)


   

(9s,10r,11r,12s,14r,15z,26s)-9,19,21,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

(9s,10r,11r,12s,14r,15z,26s)-9,19,21,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

C29H41NO5 (483.29845760000006)


   

(3e,5e,7e,15e,17e,19e,21e,23z)-9,18,20,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

(3e,5e,7e,15e,17e,19e,21e,23z)-9,18,20,26-tetramethyl-1-azacyclohexacosa-1,3,5,7,15,17,19,21,23-nonaene-2,10,11,12,14-pentol

C29H41NO5 (483.29845760000006)


   

methyl (3s,3's,3'as,6's,6as,6br,7'as,9r,11ar,11br)-3-hydroxy-3',6',10,11b-tetramethyl-11-oxo-1,2,3,3',3'a,4,5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydrospiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-4'-carboxylate

methyl (3s,3's,3'as,6's,6as,6br,7'as,9r,11ar,11br)-3-hydroxy-3',6',10,11b-tetramethyl-11-oxo-1,2,3,3',3'a,4,5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydrospiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-4'-carboxylate

C29H41NO5 (483.29845760000006)


   

1-[(4ar,5r,7s,8as)-5-{[(1r,2s,5r,9s,11r,13s,17r)-2-hydroxy-11,14-dimethyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadec-6-en-5-yl]methyl}-7-methyl-octahydro-2h-quinolin-1-yl]ethanone

1-[(4ar,5r,7s,8as)-5-{[(1r,2s,5r,9s,11r,13s,17r)-2-hydroxy-11,14-dimethyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadec-6-en-5-yl]methyl}-7-methyl-octahydro-2h-quinolin-1-yl]ethanone

C30H49N3O2 (483.3824574)


   

1-[(4ar,5r,7s,8as)-5-{[(1s,2s,5r,9s,11r,13s,17r)-2-hydroxy-11,14-dimethyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadec-6-en-5-yl]methyl}-7-methyl-octahydro-2h-quinolin-1-yl]ethanone

1-[(4ar,5r,7s,8as)-5-{[(1s,2s,5r,9s,11r,13s,17r)-2-hydroxy-11,14-dimethyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadec-6-en-5-yl]methyl}-7-methyl-octahydro-2h-quinolin-1-yl]ethanone

C30H49N3O2 (483.3824574)


   

6-[(1-acetyl-7-methyl-octahydro-2h-quinolin-5-yl)methyl]-6',12'-dimethyl-12'-azaspiro[piperidine-2,2'-tricyclo[6.2.2.0⁴,⁹]dodecan]-3-one

6-[(1-acetyl-7-methyl-octahydro-2h-quinolin-5-yl)methyl]-6',12'-dimethyl-12'-azaspiro[piperidine-2,2'-tricyclo[6.2.2.0⁴,⁹]dodecan]-3-one

C30H49N3O2 (483.3824574)


   

(10s,13s)-5-[(3r,6r)-6-hydroxy-3,6,7-trimethyloct-1-en-3-yl]-10-isopropyl-13-(methoxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

(10s,13s)-5-[(3r,6r)-6-hydroxy-3,6,7-trimethyloct-1-en-3-yl]-10-isopropyl-13-(methoxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C29H45N3O3 (483.34607400000004)


   

3-methyl-2-{[(2s)-3-methyl-2-[(2s)-1-[(2s)-2-methyldecanoyl]pyrrolidine-2-carbonyloxy]butanoyl]oxy}butanoic acid

3-methyl-2-{[(2s)-3-methyl-2-[(2s)-1-[(2s)-2-methyldecanoyl]pyrrolidine-2-carbonyloxy]butanoyl]oxy}butanoic acid

C26H45NO7 (483.319586)